全文获取类型
收费全文 | 1681篇 |
免费 | 75篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 21篇 |
妇产科学 | 28篇 |
基础医学 | 172篇 |
口腔科学 | 37篇 |
临床医学 | 73篇 |
内科学 | 400篇 |
皮肤病学 | 13篇 |
神经病学 | 150篇 |
特种医学 | 149篇 |
外科学 | 361篇 |
综合类 | 2篇 |
预防医学 | 42篇 |
眼科学 | 2篇 |
药学 | 86篇 |
中国医学 | 1篇 |
肿瘤学 | 223篇 |
出版年
2023年 | 5篇 |
2022年 | 6篇 |
2021年 | 16篇 |
2020年 | 5篇 |
2019年 | 5篇 |
2018年 | 23篇 |
2017年 | 22篇 |
2016年 | 33篇 |
2015年 | 19篇 |
2014年 | 37篇 |
2013年 | 56篇 |
2012年 | 61篇 |
2011年 | 96篇 |
2010年 | 52篇 |
2009年 | 36篇 |
2008年 | 85篇 |
2007年 | 96篇 |
2006年 | 73篇 |
2005年 | 89篇 |
2004年 | 117篇 |
2003年 | 112篇 |
2002年 | 120篇 |
2001年 | 36篇 |
2000年 | 23篇 |
1999年 | 43篇 |
1998年 | 39篇 |
1997年 | 25篇 |
1996年 | 34篇 |
1995年 | 23篇 |
1994年 | 24篇 |
1993年 | 17篇 |
1992年 | 43篇 |
1991年 | 41篇 |
1990年 | 33篇 |
1989年 | 29篇 |
1988年 | 20篇 |
1987年 | 19篇 |
1986年 | 20篇 |
1985年 | 15篇 |
1984年 | 22篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1974年 | 6篇 |
1969年 | 4篇 |
排序方式: 共有1765条查询结果,搜索用时 0 毫秒
991.
Yusuke Umemoto Takushi Oka Tomio Inoue Tomoyuki Saito 《Annals of nuclear medicine》2010,24(9):663-669
Objective
Currently, conventional radiography is the standard method for the diagnosis and evaluation of the severity of osteoarthritis (OA), but it takes a couple of years to detect cartilage loss. Magnetic resonance imaging can delineate articular cartilage and accurately assess cartilage volume and thickness, but its reliability for very early diagnosis of OA is still controversial. The purpose of this study was to confirm the potential of 18F-fluoride PET for the early diagnosis of OA by using a surgically induced rat OA model. 相似文献992.
Takeshi Murano Ukihide Tateishi Takeshi Iinuma Naoki Shimada Hiromitsu Daisaki Takashi Terauchi Noriyuki Moriyama Tomio Inoue 《Annals of nuclear medicine》2010,24(4):261-267
Objective
Unnecessary radiological examination should be avoided, particularly for children, who are more vulnerable to radiation than adults. Replacement of X-ray examination with 18F-fluoro-2-deoxy-d-glucose (18FDG) positron emission tomography/computed tomography (PET/CT) is a potential option for reduction of radiation exposure, and thus improvement in the quality of life (QOL) of patients. Therefore, this study aimed to evaluate new plans integrating 18FDG PET/CT versus current conventional imaging (CI) plans for patients with pediatric cancers. The effects of radiation exposure from the two kinds of plans were compared using shortening of the average life expectancy as an index, and the related findings and effects of radiation exposure are discussed. 相似文献993.
994.
Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C. 下载免费PDF全文
K Hashimoto C E Whitehurst T Matsubara K Hirohata P E Lipsky 《The Journal of clinical investigation》1992,89(6):1839-1848
Previous studies have shown that the gold compounds, gold sodium thiomalate (GST) and auranofin (AUR), which are effective in the treatment of rheumatoid arthritis, inhibit functional activities of a variety of cells, but the biochemical basis of their effect is unknown. In the current studies, human T cell proliferation and interleukin 2 production by Jurkat cells were inhibited by GST or AUR at pharmacologically relevant concentrations. Because it has been documented that protein kinase C (PKC) is involved in T cell activation, the capacity of gold compounds to inhibit PKC partially purified from Jurkat cells was assayed in vitro. GST was found to inhibit PKC in a dose-dependent manner, but AUR caused no significant inhibition of PKC at pharmacologically relevant concentrations. The inhibitory effect of GST on PKC was abolished by 2-mercaptoethanol. To investigate the effect of GST on the regulation of PKC in vivo, the levels of PKC activity in Jurkat cells were examined. Cytosolic PKC activity decreased slowly in a concentration- and time-dependent manner as a result of incubation of Jurkat cells with GST. To ascertain whether GST inhibited PKC translocation and down-regulation, PKC activities associated with the membrane and cystosolic fractions were evaluated after phorbol myristate acetate (PMA) stimulation of GST incubated Jurkat cells. Translocation of PKC was markedly inhibited by pretreatment of Jurkat cells with GST for 3 d, but the capacity of PMA to down-regulate PKC activity in Jurkat cells was not altered by GST preincubation. The functional impact of GST-mediated downregulation of PKC in Jurkat cells was examined by analyzing PMA-stimulated phosphorylation of CD3. Although GST preincubated Jurkat cells exhibited an increased density of CD3, PMA-stimulated phosphorylation of the gamma chain of CD3 was markedly inhibited. Specificity for the inhibitory effect of GST on PKC was suggested by the finding that GST did not alter the mitogen-induced increases in inositol trisphosphate levels in Jurkat cells. Finally, the mechanism of the GST-induced inhibition of PKC was examined in detail, using purified PKC subspecies from rat brain. GST inhibited type II PKC more effectively than type III PKC, and also inhibited the enzymatic activity of the isolated catalytic fragment of PKC. The inhibitory effect of GST on PKC activity could not be explained by competition with phospholipid or nonspecific interference with the substrate. These data suggest that the immunomodulatory effects of GST may result from its capacity to inhibit PKC activity. 相似文献
995.
Nakamizo A Amano T Zhang W Zhang XQ Ramdas L Liu TJ Bekele BN Shono T Sasaki T Benedict WF Sawaya R Lang FF 《Neuro-oncology》2008,10(3):275-291
The p53 protein plays a critical role in inducing cell cycle arrest or apoptosis. Because p53 is inactivated in human gliomas, restoring p53 function is a major focus of glioma therapy. The most clinically tested strategy for replacing p53 has been adenoviral-mediated p53 gene therapy (Ad-p53). In addition to their therapeutic implications, investigations into Ad-p53 provide model systems for understanding p53's ability to induce cell cycle arrest versus apoptosis, particularly because wild-type p53 cells are resistant to Ad-p53-induced apoptosis. Here we use Ad-p53 constructs to test the hypothesis that simultaneous phosphorylation of p53 at threonine 18 (Thr18) and serine 20 (Ser20) is causally associated with p53-mediated apoptosis. Studies using phosphorylation-specific antibodies demonstrated that p53-induced apoptosis correlates with phosphorylation of p53 at Thr18 and Ser20 but not with carboxy-terminal phosphorylation (Ser392). To prove a causal relationship between apoptosis and Thr18 and Ser20 phosphorylation of p53, the effects of an adenoviral p53 construct that was not phosphorylated (Ad-p53) was compared with a Thr18/Ser20 phosphomimetic construct (Ad-p53-18D20D) in wild-type p53 gliomas. Whereas treatment with Ad-p53 resulted only in cell cycle arrest, treatment with Ad-p53-18D20D induced dramatic apoptosis. Microarray and Western blot analyses showed that only Ad-p53-18D20D was capable of inducing expression of apoptosis-inducing proteins. Chromatin immunoprecipitation assays indicated that the protein product of Ad-p53-18D20D, but not Ad-p53, was capable of binding to apoptosis-related genes. We thus conclude that phosphorylation of Thr18 and Ser20 is sufficient for inducing p53-mediated apoptosis in glioma cells. These results have implications for p53 gene therapy and inform other strategies that aim to restore p53 function. 相似文献
996.
Takahiro Tabuchi Takahiro Hoshino Tomio Nakayama Yuri Ito Akiko Ioka Isao Miyashiro Hideaki Tsukuma 《International journal of cancer. Journal international du cancer》2013,133(4):972-983
Reducing out‐of‐pocket costs is known to improve mammography attendance, but an evidence gap remains concerning Pap smear testing. The Japanese government implemented a politically determined intervention to remove out‐of‐pocket costs for Pap smear tests and mammography attendance, costing US$148 million, in 2009. It targeted women when they reached the first year of a 5‐year age group (i.e., 20, 25, 30 years) with the aim of reducing attendance inequality. Our objective is to evaluate the intervention in terms of uptake and average cost per uptake for cancer screening attendance and to assess socioeconomic inequalities in cancer screening attendance pre‐ and postintervention. A quasi‐experimental study utilizing national repeated cross sections, observed pre‐ and postintervention, which compared intervention and comparison groups by the Difference‐in‐Differences method, was conducted. Outcome measures were uptake of cancer screening attendance resulting from the intervention with average cost per uptake and broad inequality indicators for cancer screening attendance according to socioeconomic inequality. In total, 34,043 age‐eligible, noninstitutionalized women were analyzed. Uptake among the overall population was 13.9% point in the age‐ and income‐adjusted model for Pap smear and 9.8% point for mammography, with an average cost of US$139 per uptake. The intervention increased inequality indicators in Pap smear attendance (more than +100%) but decreased inequality in mammography attendance (ranging from −12.9 to −74.1%) within the intervention group. In conclusion, removing out‐of‐pocket costs improves female cancer screening uptake in Japan but may not be cost‐saving. Although cost removal reduces inequalities in attendance for mammography, it appears to increase inequalities in Pap smear attendance. 相似文献
997.
Yoshida S Hazama S Kondo H Sakamoto K Tamesa T Ueno T Oka M 《Gan to kagaku ryoho. Cancer & chemotherapy》2006,33(12):1845-1847
We examined retrospectively the efficacy of hepatic arterial infusion (HAI) chemotherapy comparing systemic treatment as adjuvant therapy after the curative resection of hepatic metastasis from colorectal cancer. Seventeen cases of HAI and 8 of the systemic treatment were enrolled in this study. We compared the pattern of recurrent sites and the overall survival rate between the two groups. There was no difference in a patients' background. Intrahepatic recurrence rate was lower and extrahepatic recurrence rate was higher in the HAI group, but not significant. The 1-, 3-, and 5-year overall survival rate was 94, 72, and 49% in the HAI group and 100, 100, and 50% in the systemic treatment group (p = 0.29), respectively. HAI chemotherapy did not contribute to the elongation of survival time in comparison with systemic treatment. This study indicates that there is no efficacy of HAI alone after the resection of hepatic metastasis from colorectal cancer and that there is need to use systemic chemotherapy together with HAI to prevent an extrahepatic recurrence. 相似文献
998.
Araki Y Mizoguchi M Yoshimoto K Shono T Amano T Nakamizo A Suzuki SO Iwaki T Sasaki T 《Brain tumor pathology》2011,28(1):25-31
Recent reports have suggested an important clinical role for hypermethylation of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter in patients with glioblastomas. Whether MGMT protein expression is correlated
with promoter hypermethylation and patient outcomes, however, has not been elucidated. Here we describe a quantitative digital
method for assessment of MGMT-specific immunostaining, and analyze the relationship between expression levels and methylation
status of the MGMT promoter. We investigated 46 tumors from patients who received a diagnosis of glioblastoma or gliosarcoma.
Immunohistochemistry with anti-MGMT antibody and methylation-specific PCR using bisulfite-modified tumor DNA were performed.
The digital assessment method used image-analysis software to determine a digital MGMT staining index, and the results were
compared with those obtained via conventional visual assessments. The digital staining index clearly correlated with the methylation
status of MGMT promoter. In addition, the index correlated with our observational results when nuclear and cytoplasmic staining
were assessed in three different fields. Our digital assessment method enabled us to assess uncertain immunopositive samples
objectively and quantitatively, which is an important consideration when examining heterogeneous cellular staining. We expect
that this method will be useful for assessment of heterogeneous staining with any antibodies. 相似文献
999.
Tawa M Yamamizu K Geddawy A Shimosato T Imamura T Ayajiki K Okamura T 《Journal of pharmacological sciences》2011,116(2):188-196
To investigate the effect of hypoxia or hypoxia/reoxygenation on vascular smooth muscle function, mechanical response of monkey coronary artery without endothelium was studied under normoxia, hypoxia, and hypoxia/reoxygenation. Hypoxia or hypoxia/reoxygenation impaired the relaxation by nitroglycerin or isosorbide dinitrate but not that by 8-bromoguanosine-3',5'-cyclic monophosphate or isoproterenol. Tempol restored the impaired relaxation by nitroglycerin or isosorbide dinitrate, but superoxide dismutase had no effect. Apocynin, an NADPH oxidase inhibitor, improved the nitroglycerin-induced relaxation under hypoxia, but not under reoxygenation. Under combined treatment of apocynin with oxypurinol (xanthine oxidase inhibitor), rotenone (mitochondria electron transport inhibitor), or both, hypoxic impairment of vasorelaxation was restored more effectively. Similarly, impairment of the nitroglycerin-induced vasorelaxation under hypoxia/reoxygenation was restored by combined treatment with three inhibitors, apocynin, oxypurinol, and rotenone. Increase in superoxide production under hypoxia tended to be inhibited by apocynin and that under hypoxia/reoxygenation was abolished by combined treatment with three inhibitors. These findings suggest that increased intracellular superoxide production under hypoxia or hypoxia/reoxygenation attenuates vasodilation mediated with a nitric oxide/soluble guanylyl cyclase, but not adenylyl cyclase, signaling pathway. The main source of superoxide production under hypoxia seems to be different from that under reoxygenation: superoxide is produced by NADPH oxidase during hypoxia, whereas it is produced by xanthine oxidase, mitochondria, or both during reoxygenation.[Supplementary Figure: available only at http://dx.doi.org/10.1254/jphs.11031FP]. 相似文献
1000.
Mizoguchi M Yoshimoto K Ma X Guan Y Hata N Amano T Nakamizo A Suzuki SO Iwaki T Sasaki T 《Brain tumor pathology》2012,29(3):148-153
Recent developments in molecular analysis have revealed genetic alterations in human gliomas. Loss of heterozygosity (LOH) is a critical molecular marker for classification of human glioma, and is useful for predicting outcome. Our previous LOH study identified a small subgroup of glioblastoma (GBM), with 1p/19q co-deletion, with a favorable clinical outcome. In this study, we investigated molecular pathological features of eight GBM with 1p/19q co-deletion compared with "classic" GBM and anaplastic oligodendroglioma (AO). We estimated EGFR gene amplification, EGFRvIII expression, CDKN2A (p16) homozygous deletion, and isocitrate dehydrogenase 1/2 (IDH1/2) gene mutations. We also conducted an analysis of the expression of proneural genes (DLL3, OLIG2, SOX2). On histopathological review, only one GBM was diagnosed as glioblastoma with oligodendroglioma component (GBMO). Loss of chromosomes 10 and 17p is common, and neither IDH1/2 mutations nor EGFRvIII expression were detected in GBM with 1p/19q co-deletion. The expression profile revealed high expression of the OLIG2 gene in this subgroup. High expression of proneural gene OLIG2 without EGFRvIII expression may be associated with a favorable clinical outcome; however, IDH1/2 gene status and the extent of LOH regions may indicate that this small subgroup of GBM is a distinct genetic subgroup from oligodendroglial tumors. 相似文献